Your browser doesn't support javascript.
loading
Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study.
Mussetti, A; Rius-Sansalvador, B; Moreno, V; Peczynski, C; Polge, E; Galimard, J E; Kröger, N; Blaise, D; Peffault de Latour, R; Kulagin, A; Mousavi, A; Stelljes, M; Hamladji, R M; Middeke, J M; Salmenniemi, U; Sengeloev, H; Forcade, E; Platzbecker, U; Reményi, P; Angelucci, E; Chevallier, P; Yakoub-Agha, I; Craddock, C; Ciceri, F; Schroeder, T; Aljurf, M; Ch, Koenecke; Moiseev, I; Penack, O; Schoemans, H; Mohty, M; Glass, B; Sureda, A; Basak, G; Peric, Z.
Afiliação
  • Mussetti A; Department of Haematology, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain. amussetti@iconcologia.net.
  • Rius-Sansalvador B; Biomarkers and Susceptibility Unit (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Moreno V; ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Peczynski C; Biomarkers and Susceptibility Unit (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.
  • Polge E; ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Galimard JE; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital, INSERM Unité Mixte de Recherche (UMR)-S 938, Sorbonne University, Paris, France.
  • Kröger N; EBMT Global Committee (Shanghai and Paris Offices) and Acute Leukaemia Working Party, Hospital Saint-Antoine APHP and Sorbonne University, Paris, France.
  • Blaise D; EBMT, Statistics Unit, Paris, France.
  • Peffault de Latour R; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kulagin A; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
  • Mousavi A; Service d'Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • Stelljes M; Université Paris Diderot, Institut Universitaire d'Hématologie, Sorbonne Paris Cité, Paris, France.
  • Hamladji RM; Raisa Memorial (RM) Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russia.
  • Middeke JM; Shariati Hospital, Haematology-Oncology and BMT Research, Tehran, Islamic Republic of Iran.
  • Salmenniemi U; Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Sengeloev H; Centre Pierre et Marie Curie, Service Hématologie Greffe de Moëlle, Alger, Algeria.
  • Forcade E; Med. Klinik I, University Hospital, TU Dresden, Germany.
  • Platzbecker U; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
  • Reményi P; Bone Marrow Transplant Unit Copenhagen, Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Angelucci E; CHU Bordeaux, Service d'hématologie Clinique et Thérapie Cellulaire, 33000, Pessac, France.
  • Chevallier P; University Hospital Leipzig, Leipzig, Germany.
  • Yakoub-Agha I; Department of Haematology and Stem Cell Transplant, Dél-pesti Centrumkórház - Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary.
  • Craddock C; Haematology and Cellular Therapy Unit. IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Ciceri F; CHU Nantes, Nantes, France.
  • Schroeder T; CHU de Lille LIRIC, INSERM U995, Université de Lille, Lille, France.
  • Aljurf M; Department of Haematology, University Hospital Birmingham NHS Trust, Queen Elizabeth Medical Centre, Edgbaston, Birmingham, UK.
  • Ch K; Haematology & Bone Marrow Transplant, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Moiseev I; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
  • Penack O; Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Schoemans H; Hannover Medical School, Hannover, Germany.
  • Mohty M; R.M.Gorbacheva Memorial Institute of Oncology, Haematology and Transplantation, Pavlov First Saint Petersburg State Medical University, Saint-Petersburg, Russian Federation.
  • Glass B; Department of Haematology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Sureda A; Department of Haematology, University Hospitals Leuven, Leuven, Belgium.
  • Basak G; Department of Public Health and Primary Care, ACCENT VV, KU Leuven - University of Leuven, Leuven, Belgium.
  • Peric Z; Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Bone Marrow Transplant ; 59(2): 232-238, 2024 02.
Article em En | MEDLINE | ID: mdl-38007531
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Transplante de Células-Tronco Hematopoéticas Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article